Valuation Johnson & Johnson

Equities

Market Closed - Nyse Other stock markets 04:00:02 17/04/2026 HKT			Pre-market 19:34:57
234.54 ^USD	-1.73%		236.20	+0.71%

04:00pm	Moberg Pharma proposes Lars Johansson as new Chairman	FW
04-16	MeiraGTx Acquires Bota-vec From Johnson & Johnson; Reports Positive Three-Year Early-Stage Data From AAV-hAQP1 Program in Xerostomia	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	448,463	461,875	376,932	349,226	500,242	564,916	-	-
Change	-	2.99%	-18.39%	-7.35%	43.24%	12.93%	-	-
Enterprise Value (EV) ¹	450,606	478,015	383,337	361,338	528,042	582,903	572,122	558,531
Change	-	6.08%	-19.81%	-5.74%	46.14%	10.39%	-1.85%	-2.38%
P/E ratio	21.8x	26.2x	11.4x	25.1x	18.8x	25.1x	22.7x	21.2x
PBR	6.05x	6.13x	5.83x	4.88x	6.14x	6.31x	5.6x	4.94x
PEG	-	-1.9x	0x	-0.4x	0.2x	-1.6x	2.2x	2.85x
Capitalization / Revenue	4.78x	4.86x	4.43x	3.93x	5.31x	5.6x	5.28x	4.94x
EV / Revenue	4.81x	5.03x	4.5x	4.07x	5.61x	5.78x	5.34x	4.88x
EV / EBITDA	12.3x	14.6x	12.6x	12.3x	15.9x	15.7x	14.3x	12.9x
EV / EBIT	15.4x	16x	14x	13.7x	17.4x	17.4x	15.7x	14x
EV / FCF	22.8x	27.8x	21x	18.2x	26.8x	22x	19.4x	17.7x
FCF Yield	4.38%	3.6%	4.76%	5.49%	3.73%	4.55%	5.15%	5.65%
Dividend per Share ²	4.19	4.45	4.7	4.91	5.14	5.334	5.568	5.781
Rate of return	2.46%	2.52%	3%	3.39%	2.48%	2.27%	2.37%	2.46%
EPS ²	7.81	6.73	13.72	5.79	11.03	9.328	10.31	11.08
Distribution rate	53.6%	66.1%	34.3%	84.8%	46.6%	57.2%	54%	52.2%
Net sales ¹	93,775	94,943	85,159	88,821	94,193	100,894	107,072	114,419
EBITDA ¹	36,634	32,630	30,414	29,288	33,261	37,160	40,058	43,266
EBIT ¹	29,244	29,965	27,460	26,466	30,358	33,545	36,501	39,991
Net income ¹	20,878	17,941	35,153	14,066	26,804	21,679	24,298	25,943
Net Debt ¹	2,143	16,140	6,405	12,112	27,800	17,987	7,206	-6,386
Reference price ²	170.35	176.66	156.58	145.05	207.63	234.54	234.54	234.54
Nbr of stocks (in thousands)	2,632,597	2,614,484	2,407,279	2,407,623	2,409,295	2,408,613	-	-
Announcement Date	25/1/22	24/1/23	23/1/24	22/1/25	21/1/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JOHNSON & JOHNSON	25.14x	5.78x	15.69x	2.27%	565B
ELI LILLY AND COMPANY	26.9x	10.08x	20.2x	0.75%	809B
ABBVIE INC.	23.52x	6.29x	12.77x	3.31%	370B
ASTRAZENECA PLC	25.36x	5.24x	14.79x	1.65%	312B
MERCK & CO., INC.	27.32x	4.77x	14.81x	2.93%	285B
NOVARTIS AG	20.77x	5.58x	13.5x	2.95%	286B
AMGEN INC.	23.43x	6.05x	10.71x	2.88%	189B
NOVO NORDISK A/S	12.28x	4.38x	9.16x	4.19%	180B
GILEAD SCIENCES, INC.	18.81x	5.88x	10.82x	2.34%	172B
Average	22.61x	6.00x	13.61x	2.59%	351.84B
Weighted average by Cap.	24.05x	6.72x	15.20x	2.21%